Table 2 Patient-reported Outcome Measures (PROMs) administered at baseline, 3-month, 6-month and 9-month follow-up
From: Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial
Construct | Instrument |
|---|---|
Pain intensity and function | • Brief Pain Inventory (BPI) [43] |
Mood | • Hospital Anxiety and Depression Scale (HADS) [44] |
Substance use | • World Mental Health Composite International Diagnostic Interview (CIDI) substance use disorders module [45] • Current Opioid Misuse Measure (COMM) [46] • Self-Reported Misuse, Abuse, and Diversion (SR-MAD) [47] |
Medication use and adherence | • Quantitative Analgesic Questionnaire (QAQ) [48] • AIDS Clinical Trials Group (ACTG) antiretroviral adherence questionnaire [49] |
Relationship with provider | • Trust in Provider Scale (TIPS) [50] • Clinician & Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) survey (selected questions) [51] |
Stigma and discrimination | • HIV Stigma Scale (HSS) [52] • Internalized Stigma of Chronic Pain (ISCP) [53] • Brief Perceived Ethnic Discrimination Questionnaire-Community Version (BPEDQ-CV) [54] |